An epidemic in Cuba of optic neuropathy, sensorineural deafness, peripheral sensory neuropathy and dorsolateral myeloneuropathy.
An epidemic outbreak of peripheral neuropathy affected Cuba in 1992-93 resulting in 50,862 cases (national cumulative incidence rate (CIR) 461.4 per 100,000). Clinical forms included retrobulbar optic neuropathy, sensory and dysautonomic peripheral neuropathy, dorsolateral myeloneuropathy, sensorineural deafness, dysphonia and dysphagia, spastic paraparesis, and mixed forms. For epidemiological purposes, cases were classified as optic forms (CIR 242.39) or peripheral forms (CIR 219.25). Increased risk was found among smokers (odds ratio (OR) 4.9), those with history of missing meals (OR 4.7) resulting in lower intake of animal protein, fat, and foods that contain B-vitamins, combined drinking and smoking (OR 3.5), weight loss (OR 2.8), excessive sugar consumption (OR 2.7) and heavy drinking (OR 2.3). Optic neuropathy was characterized by decreased vision, bilateral and symmetric central or cecocentral scotomata, and loss of color vision due to selective lesion of the maculopapillary bundles. Peripheral neuropathy was a distal axonopathy lesion affecting predominantly large myelinated axons. Deafness produced selective high frequency (4-8 kHz) hearing loss. Myelopathy lesions combined dorsal column deficits and pyramidal involvement of lower limbs with spastic bladder. Clinical features were those of Strachan syndrome and beriberi. Intensive search for neurotoxic agents, in particular organophosphorus esters, chronic cyanide, and trichloroethylene intoxication, yielded negative results. Treatment of patients with B-group vitamins and folate produced rewarding results. Most patients improved significantly and less than 0.1% of them remained with sequelae; there were no fatal cases. Supplementation of multivitamins to the entire Cuban population resulted in curbing of the epidemic. Overt malnutrition was not present, but a deficit of micronutrients, in particular thiamine, cobalamine, folate and sulfur amino acids appears to have been a primary determinant of this epidemic.
Román
G C
GC
Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001361:Avitaminosis / Q000188:drug therapy / Q000453:epidemiology*; D001602:Beriberi / Q000453:epidemiology; D016022:Case-Control Studies; D002648:Child; D003462:Cuba / Q000453:epidemiology; D003638:Deafness / Q000453:epidemiology; D004196:Disease Outbreaks; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D005502:Food / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009748:Nutrition Disorders / Q000453:epidemiology; D009901:Optic Nerve Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D015493:Paraparesis, Tropical Spastic / Q000453:epidemiology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D011057:Politics; D012678:Sensation Disorders / Q000453:epidemiology; D014118:Toxins, Biological / Q000032:analysis; D014131:Trace Elements / Q000172:deficiency; D014803:Vitamin B Complex / Q000627:therapeutic use
D014118:Toxins, Biological; D014131:Trace Elements; D014803:Vitamin B Complex; D005492:Folic Acid